EMA Says Concluded Sotrovimab Can Be Used To Treat COVID-19 In Adults And Adolescents Not Requiring Supplemental Oxygen Therapy And Risk Of Progressing To Severe COVID-19; Says A Rolling Review Of Sotrovimab, Which Started On 7 May, Is Ongoing